{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T21:52:09Z","timestamp":1698702729433},"reference-count":20,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2161,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1111\/j.1365-2893.2009.01204.x","type":"journal-article","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T08:26:06Z","timestamp":1256113566000},"source":"Crossref","is-referenced-by-count":9,"title":["Hyperinsulinaemia reduces the 24-h virological response to PEG-interferon therapy in patients with chronic hepatitis C and insulin resistance"],"prefix":"10.1111","author":[{"given":"G.","family":"Bortoletto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Scribano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Realdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Marcolongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mirandola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bonisegna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Noventa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Martines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1111\/j.1365-2893.2009.01204.x-BIB1","first-page":"35","article-title":"Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium","volume":"6","author":"Anonymous","year":"1999","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1365-2893.2009.01204.x-BIB2","unstructured":"2Centers for Disease Control and Prevention (US). Division of viral hepatitis. US disease burden data: 1980-2003. Available at: http:\/\/www.cdc.gov.myaccess.library.utoronto.ca\/ncidod\/disease\/hepatitis\/resource\/PDFs\/disease_burden2004.pdf (accessed January 18, 2008)."},{"issue":"11","key":"10.1111\/j.1365-2893.2009.01204.x-BIB3","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ncpgasthep1274","article-title":"Interferon-based therapy for chronic hepatitis C: current and future perspectives","volume":"5","author":"Zeuzem","year":"2008","journal-title":"Nat Clin Pract Gastroenterol Hepatol."},{"issue":"4","key":"10.1111\/j.1365-2893.2009.01204.x-BIB4","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2008.07.013","article-title":"Treatment predictors of a sustained virologic response in hepatitis B and C","volume":"49","author":"Kau","year":"2008","journal-title":"J Hepatol."},{"issue":"Suppl 2","key":"10.1111\/j.1365-2893.2009.01204.x-BIB5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1055\/s-2004-832925","article-title":"Predictors of response to therapy for chronic hepatitis C","volume":"24","author":"Ferenci","year":"2004","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1111\/j.1365-2893.2009.01204.x-BIB6","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jhep.2008.12.017","article-title":"Insulin resistance predicts response to peginterferon-alpha\/ribavirin combination therapy in chronic hepatitis C patients","volume":"50","author":"Dai","year":"2009","journal-title":"J Hepatol"},{"issue":"3","key":"10.1111\/j.1365-2893.2009.01204.x-BIB7","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.gastro.2004.12.049","article-title":"Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients","volume":"128","author":"Romero-G\u00f3mez","year":"2005","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1111\/j.1365-2893.2009.01204.x-BIB8","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/hep.21782","article-title":"Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: insulin resistance and response to antiviral therapy","volume":"46","author":"Persico","year":"2007","journal-title":"Hepatology"},{"issue":"6 pt 2","key":"10.1111\/j.1365-2893.2009.01204.x-BIB9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S1262-3636(08)74606-8","article-title":"Hepatitis C virus and glucose and lipid metabolism","volume":"34","author":"Alaei","year":"2008","journal-title":"Diabetes Metab"},{"issue":"3","key":"10.1111\/j.1365-2893.2009.01204.x-BIB10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1478-3231.2007.01630.x","article-title":"Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients","volume":"28","author":"Imazeki","year":"2008","journal-title":"Liver Int"},{"issue":"6","key":"10.1111\/j.1365-2893.2009.01204.x-BIB11","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/hep.22269","article-title":"Hepatitis C virus infection: molecular pathways to metabolic syndrome","volume":"47","author":"Sheikh","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1111\/j.1365-2893.2009.01204.x-BIB12","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1128\/JVI.01672-07","article-title":"Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt\/protein kinase B signaling pathway for insulin resistance","volume":"82","author":"Banerjee","year":"2008","journal-title":"J Virol"},{"issue":"4","key":"10.1111\/j.1365-2893.2009.01204.x-BIB13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/gut.2005.069674","article-title":"Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1","volume":"55","author":"Walsh","year":"2006","journal-title":"Gut"},{"issue":"7","key":"10.1111\/j.1365-2893.2009.01204.x-BIB14","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/135965350801300711","article-title":"A hepatitis C viral kinetic model that allows for time-varying drug effectiveness","volume":"13","author":"Shudo","year":"2008","journal-title":"Antivir Ther"},{"issue":"5","key":"10.1111\/j.1365-2893.2009.01204.x-BIB15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet Med"},{"issue":"2","key":"10.1111\/j.1365-2893.2009.01204.x-BIB16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jhep.2008.03.033","article-title":"Pioglitazone in chronic hepatitis C not responding to pegylated interferon-alpha and ribavirin","volume":"49","author":"Overbeck","year":"2008","journal-title":"J Hepatol"},{"issue":"Suppl. 4","key":"10.1111\/j.1365-2893.2009.01204.x-BIB17","first-page":"380A","article-title":"Metformin with Peginterferon Alfa-2a and ribavirin in the treatment of na\u00efve genotype 1 chronic hepatitis C patients with insulin resistance (TRIC-1): final results of a randomized and double-blinded trial","volume":"48","author":"Romero-G\u00f3mez","year":"2008","journal-title":"Hepatology"},{"issue":"Suppl. 4","key":"10.1111\/j.1365-2893.2009.01204.x-BIB18","article-title":"Pioglitazone improves early virologic kinetic response to Peg IFN\/RBV combination therapy in hepatitis C genotype 1 na\u00efve pts","volume":"48","author":"Elgouhari","year":"2008","journal-title":"Hepatology"},{"issue":"Suppl. 4","key":"10.1111\/j.1365-2893.2009.01204.x-BIB19","article-title":"A randomized, double-blind, placebo-controlled study of PPAR-gamma agonist pioglitazone given in combination with peginterferon and ribavirin in patients with genotype-1 chronic hepatitis C","volume":"48","author":"Conjeevaram","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01204.x-BIB20","doi-asserted-by":"crossref","unstructured":"20 Franceschini L , Marcolongo M , Bortoletto G , Alberti A . A non-canonical interferon-alpha pathway, through IRS1, might be involved in the reduced antiviral therapy respnse in patients with insulin resistance and chronic hepatitis C. . J Hepatol 2009; 50(Suppl. 1): 321.","DOI":"10.1016\/S0168-8278(09)60323-8"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.2009.01204.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2893.2009.01204.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T07:33:06Z","timestamp":1685172786000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2893.2009.01204.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":20,"URL":"https:\/\/doi.org\/10.1111\/j.1365-2893.2009.01204.x","relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}